Human monocyte-derived dendritic cells produce macrophage colony-stimulating factor: Enhancement of c-fms expression by interleukin-10

European Journal of Immunology

Volumn 28, Issue 8, 1998, Pages 2283-2288

  Rieser, Claudia ^a   Ramoner, Reinhold ^a   Böck, Günther ^b   Deo, Yashwant M ^c   Höltl, Lorenz ^a   Bartsch, Georg ^a   Thurnher, Martin ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c MEDAREX INC   (United States)

Author keywords

CD115; Dendritic cell; Fc receptor; IL 10; Macrophage colony stimulating factor

Indexed keywords

COLONY STIMULATING FACTOR 1; FC RECEPTOR; INTERLEUKIN 10; LYMPHOCYTE ANTIGEN; WORTMANNIN;

ARTICLE; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANTIGENS, SURFACE; BASE SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DNA PRIMERS; ENZYME INHIBITORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MONOCYTES; POLYMERASE CHAIN REACTION; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RNA, MESSENGER;

EID: 0031901854     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199808)28:08<2283::AID-IMMU2283>3.0.CO;2-X     Document Type: Article

References (23)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Cella, M., Sallusto, F. and Lanzavecchia, A., Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 1997. 9: 10-16.
3. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994. 179: 1109-1118.
4. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 1995. 182: 389-400.
5. + human blood dendritic cells for active tumor immunotherapy. Exp. Hematol. 1997. 25: 232-237.
6. Romani, N., Reider, D., Heuer, M., Ebner, S., Kämpgen, E., Eibl, B., Niederwieser, D. and Schuler, G., Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 1996. 196: 137-151.
7. Rieser, C., Böck, G., Klocker, H., Bartsch, G. and Thurnher, M., Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 1997. 186: 1603-1608.
8. Chapuis, R, Rosenzwajg, M., Yagello, M., Ekman, M., Biberfeld, P. and Gluckman, J. C., Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 1997. 27: 431-441.
9. + blood dendritic cells. Blood 1995. 86: 3295-3301.
10. Shpetner, H., Joly, M., Hartley, D. and Corvera, S., Potential sites of Pl-3 kinase function in the endocytic pathway revealed by the Pl-3 kinase inhibitor, wortmannin. J. Cell Biol. 1996. 132: 595-605.
11. Arcaro, A. and Wymann, M. P., Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 1993. 296: 297-301.
12. Hashimoto, S., Yamada, M., Motoyoshi, K. and Akagawa, K. S., Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood 1997. 89: 315-321.
13. Lauener, R. P., Goyert, S. M., Geha, R. S. and Vercelli, D., Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur. J. Immunol. 1990. 20: 2375-2381.
14. Morel, A. S., Quaratino, S., Douek, D. C. and Londei, M., Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur. J. immunol. 1997. 27: 26-34.
15. Deo, Y. M., Graziano, R. F., Repp, R. and van de Winkel, J. G., Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies, Immunol. Today 1997. 18: 127-135.
16. Clynes, R., Takechi, Y., Moroi, Y., Houghton, A. and Ravetch, J. V., Fc receptors are required in passive and active immunity to melanoma. Proc. Natl. Acad. Sci. USA 1998. 95: 652-656.
17. Amigorena, S., Lankar, D., Briken, V., Gapin, L., Viguier, M. and Bonnerot, C., Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens. J. Exp. Med. 1998. 187: 505-515.
18. Steinman, R. M. and Swanson, J., The endocytic activity of dendritic cells. J. Exp. Med. 1995. 182: 283-288.
19. Lanzavecchia, A., Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 1996. 8: 348-354.
20. Racoosin, E. L. and Swanson, J. A., Macrophage colony-stimulating factor (rM-CSF) stimulates pinocytosis in bone marrow-derived macrophages. J. Exp. Med. 1989. 170: 1635-1648.
21. Araki, N., Johnson, M. T. and Swanson, J. A., A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J. Cell Biol. 1996. 135: 1249-1260.
22. Bukowski, R. M., Budd, G. T., Gibbons, J. A. et al., Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects. J. Clin. Oncol. 1994. 12: 97-106.
23. Dorsch, M., Hock, H., Kunzendorf, U., Diamantstein, T. and Blankenstein, T., Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression. Eur. J. Immunol. 1993. 23: 186-190.